Lord, Abbett & Co’s SkinHealth Systems SKIN Stock Holding History

Lord, Abbett & Co’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,422	Closed	-$7.68M	–	580
2023 Q1	$7.68M	Buy	+30,422	New	+$7.04M	0.03%	432
2022 Q1	–	Sell	-112,342	Closed	-$54.3M	–	684
2021 Q4	$54.3M	Buy	112,342 +3,204	+3%	+$1.65M	0.12%	248
2021 Q3	$56.7M	Buy	+109,138	New	+$48M	0.14%	229

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co's SKIN Position: Q2 2023 in Review

Lord, Abbett & Co sold out of SkinHealth Systems (SKIN) in Q2 2023, closing a stake of 30,422 shares — an estimated $7.68M sold.

Lord, Abbett & Co first reported a position in SKIN in Q3 2021 and held it in 3 quarters. The position peaked at $56.7M in Q3 2021. 135 funds tracked by Wall St. Rank hold SKIN as of Q2 2023.

Lord, Abbett & Co reported no remaining SkinHealth Systems position as of Q2 2023 after selling out during the quarter.
Lord, Abbett & Co sold 30,422 SkinHealth Systems shares in Q2 2023, an estimated $7.68M.
Lord, Abbett & Co first reported a position in SkinHealth Systems in Q3 2021 and held it in 3 quarters.
Lord, Abbett & Co's SkinHealth Systems position peaked at $56.7M in Q3 2021.
135 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2023.

Based on Lord, Abbett & Co's 13F filing for Q2 2023, filed 14 Aug 2023.